CIK 0001861123 · <br>Emerging growth company
Eikon Therapeutics, Inc.
Sign in to watch- Ticker
- EIKN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 842807586
- Phone
- 341-777-0566
- Business address
- 230 HARRIET TUBMAN WAY, MILLBRAE, CA, 94030
- 8-K Event Bylaws or fiscal year change
- 424B4 Offering Prospectus
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- S-1MEF Other S-1MEF
- CERT Other Certification
- EFFECT Other Notice of Effectiveness
- 8-A12B Other Registration of Securities
- S-1/A Offering Registration Statement
Page 3 of 4 · 69 filings